uniQure director David D. Meek plans $193K share sale

The planned sale is tied to a 10b51 plan adopted May 26, 2026.

Available on EDGAR 11/06/2026 - 04:00 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

For uniQure N.V. (QURE), director David D. Meek reported a planned sale of 9,080 ordinary shares, with an aggregate market value of $192,950.00, scheduled for November 6, 2026. The shares are described as vested compensation, and the sale is pursuant to a 10b51 plan adopted May 26, 2026. Citigroup Global Markets, Inc. is listed as broker, and Nasdaq is listed as the exchange.

Key Figures

Ordinary shares to be sold: 9,080 shares Aggregate market value: $192,950.00 Ordinary shares outstanding: 70,138,860 shares +2 more

5 metrics

Ordinary shares to be sold 9,080 shares Planned sale scheduled for November 6, 2026

Aggregate market value $192,950.00 Planned sale

Ordinary shares outstanding 70,138,860 shares Issuer shares outstanding listed in the notice

Planned sale date November 6, 2026 Approximate date of sale

Trading plan adoption date May 26, 2026 Date the 10b51 plan was adopted

Key Terms

10b51 plan, aggregate market value, vested shares, Rule 144

4 terms

10b51 plan regulatory

"Shares sold are pursuant to the established 10b51 plan"

aggregate market value financial

"192950.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

vested shares financial

"Ordinary Shares | 11/06/2026 | Vested shares"

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QURE shares does David D. Meek plan to sell?

David D. Meek, a uniQure director, reported a planned sale of 9,080 ordinary shares with an aggregate market value of $192,950.00, scheduled for November 6, 2026. The shares are listed as vested compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001555337
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Meek David D.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	9080	192950.00	70138860	11/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/06/2026	Vested shares	UniQure N.A.			9080	11/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares sold are pursuant to the established 10b51 plan adopted May 26 2026. under securities to be sold date acquired and payment are various dates
Date of Notice	11/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)